Cancer Drugs Put Europe’s New HTA System to Its First Real Test

Until now, European cancer medicine access has often followed a fragmented pathway. A product could receive central EMA authorisation, then face separate HTA processes across…

Read more

Free IPM Alliance Newsletter

Clinically reviewed health and wellness insights sent straight to your inbox.

Educational Courses

See all →

Lorem ipsum dolor sit amet

60-minute course on diagnostic principles, testing approaches, data interpretation, and patient-focused communication in hematologic malignancies.

Lorem ipsum dolor sit amet

60-minute course on diagnostic principles, testing approaches, data interpretation, and patient-focused communication in hematologic malignancies.

EAPM Contributes to Strategic Alignment at JA PCM Kick-Off Meeting in Brussels

Brussel
May 22, 2026

Multimedia

See all →

Lorem ipsum